SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-003411
Filing Date
2022-02-08
Accepted
2022-02-08 06:49:07
Documents
46
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 542188
2 ex31-1.htm EX-31.1 18499
3 ex31-2.htm EX-31.2 18566
4 ex32-1.htm EX-32.1 10512
5 ex32-2.htm EX-32.2 10486
  Complete submission text file 0001493152-22-003411.txt   2598026

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20211231.xsd EX-101.SCH 24480
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sonn-20211231_cal.xml EX-101.CAL 33339
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sonn-20211231_def.xml EX-101.DEF 77457
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20211231_lab.xml EX-101.LAB 196070
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20211231_pre.xml EX-101.PRE 147500
40 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 297391
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 22599256
SIC: 2834 Pharmaceutical Preparations